Table 3. Predictive ability of A-FABP and chemerin for metabolic syndrome.

	Overall OR (95% CI)	p	Men	p	Women	p
Model 0
A-FABP	3.2 (1.6–6.4)	0.001	6.9 (1.8–25.1)	0.004	2.3 (0.9–5.8)	0.09
Chemerin	2.7 (0.8–8.7)	0.1	2.6 (0.6–12.6)	0.2	2.4 (0.4–14.7)	0.34
Model 1
A-FABP	3.3 (1.6–6.7)	0.001	8.7 (2.2–33.7)	0.002	1.9 (0.7–5.1)	0.2
Chemerin	2.6 (0.8–8.5)	0.12	3.4 (0.7–17.3)	0.1	2.1 (0.3–13.5)	0.4
Model 2
A-FABP	2.3 (1.1–5.0)	0.03	5.5 (1.4–22.7)	0.02	1.3 (0.4–3.9)	0.6
Chemerin	2.4 (0.7–8.5)	0.17	2.85 (0.5–15.6)	0.3	2.1 (0.3–15.7)	0.5
Model 3
A-FABP	2.3 (1.1–5.0)	0.03	5.2 (1.2–22)	0.02	0.9 (0.3–3.0)	0.9
Chemerin	1.7 (0.5–6.0)	0.41	2.0 (0.4–11.4)	0.4	1.3 (0.2–9.5)	0.3

Model 0: no adjustment.

Model 1: adjusted for age.

Model 2: adjusted for age, body mass index.

Model 3: adjusted for age, visceral adipose tissue area.

A-FABP, adipocyte fatty acid-binding protein.